SuperworthDENTSPLY SIRONA profit margin XRAY
Gross, operating and net profit as a share of revenue over the last twelve months, from 2009.
- Net margin, 12 months
- −15.0%
- Operating margin, 12 months
- −8.5%
- Net margin on a year earlier
- +10.9 pts
- Peer median
- 7.3%
Over the twelve months to Jun 30, 2026, DENTSPLY SIRONA kept −15.0% of its revenue as net profit, with an operating margin of −8.5% and a gross margin of 49.5%.
Five years earlier its net margin was 8.9%.
The median for 10 medical instruments and supplies stocks of a similar size is 7.3%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −16.3% | −11.5% | 50.0% |
| FY2024 | −24.0% | −23.2% | 51.6% |
| FY2023 | −3.3% | −2.1% | 52.6% |
| FY2022 | −24.2% | −23.9% | 54.2% |
| FY2021 | 9.7% | 14.4% | 55.5% |
| FY2020 | −2.2% | −0.1% | 49.6% |
| FY2019 | 6.5% | 9.0% | 53.7% |
| FY2018 | −25.4% | −24.0% | 51.9% |
| FY2017 | −38.8% | −39.1% | 54.8% |
| FY2016 | 11.5% | 12.1% | 53.4% |
| FY2015 | 9.4% | 14.0% | 56.7% |
| FY2014 | 11.0% | 15.2% | 54.7% |
| FY2013 | 10.6% | 14.2% | 53.5% |
| FY2012 | 10.7% | 13.0% | 53.1% |
| FY2011 | 9.6% | 11.9% | 50.2% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −15.0% | +10.9 pts | −8.5% | |
| Q1 FY26 | −17.1% | +7.4 pts | −14.1% | |
| Q4 FY25 | −16.3% | +7.7 pts | −11.5% | |
| Q3 FY25 | −24.3% | −13.7 pts | −21.9% | |
| Q2 FY25 | −25.9% | −21.1 pts | −28.2% | |
| Q1 FY25 | −24.4% | −22.0 pts | −23.1% | |
| Q4 FY24 | −24.0% | −20.7 pts | −23.2% | |
| Q3 FY24 | −10.6% | −5.2 pts | −7.6% | |
| Q2 FY24 | −4.7% | +21.3 pts | −1.8% | |
| Q1 FY24 | −2.4% | +24.0 pts | −1.0% | |
| Q4 FY23 | −3.3% | +20.9 pts | −2.1% | |
| Q3 FY23 | −5.4% | +14.8 pts | −2.4% |
Against its peers
Companies in Medical - Instruments & Supplies nearest DENTSPLY SIRONA's size, closest first, today.
| Company | Profit margin |
|---|---|
| XRAYDENTSPLY SIRONA | −15.0% |
| LMATLemaitre Vascular | 25.0% |
| INSPInspire Medical Systems | 15.0% |
| UFPTUFP Technologies | 11.4% |
| EYENational Vision | 2.5% |
| CDRECadre | 5.3% |
| BVSBioventus | 9.4% |
| ATRCAtriCure | 1.9% |
| STAAStaar Surgical | 1.1% |
| WRBYWarby Parker | 0.8% |
| IRMDIradimed | 26.7% |
| Peer median | 7.3% |
Where DENTSPLY SIRONA ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on DENTSPLY SIRONA
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.